David W. Reid
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
David W. Reid has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Alissa L.W. Kleinhenz
Center for Human Disease Modeling, Duke University Medical Center, Durham, North Carolina, USA
1 shared publication - Beryl Royer-Bertrand
Department of Medical Genetics, University of Lausanne, Lausanne, Switzerland
1 shared publication - Carlo Rivolta
Institute of Molecular and Clinical Ophthalmology Basel (IOB), Basel, 4031, Switzerland
1 shared publication - Carol Saunders
Department of Pathology and Laboratory Medicine Children's Mercy Hospital Kansas City Missouri USA
1 shared publication - Christopher V. Nicchitta
Department of Cell Biology, Duke University Medical Center, Durham, NC 27710
1 shared publication - Cong Yu
BGI-shenzhen, Shenzhen, China
1 shared publication
Latest Publications
- Open Access
- 1 August 2024
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 9 (17)
An atypical form of 60S ribosomal subunit in Diamond-Blackfan anemia linked to RPL17 variants
Diamond-Blackfan anemia syndrome (DBA) is a ribosomopathy associated with loss-of-function variants in more than 20 ribosomal protein (RP) genes. Here, we report the genetic, functional, and biochemical dissection of 2 multigenerational pedigrees with variants in RPL17 , a large ribosomal subunit protein–encoding gene. Affected individuals had clinical features and erythroid proliferation defects consistent with DBA. Further, RPL17/uL22 depletion resulted in anemia and micrognathia in zebrafish larvae, and in vivo complementation studies indicated that RPL17 variants were pathogenic. Lymphoblastoid cell lines (LCLs) derived from patients displayed a ribosomal RNA maturation defect reflecting haploinsufficiency of RPL17 . The proteins encoded by RPL17 variants were not incorporated into ribosomes, but 10%–20% of 60S ribosomal subunits contained a short form of 5.8S rRNA (5.8S C ), a species that is marginal in normal cells. These atypical 60S subunits were actively engaged in translation. Ribosome profiling showed changes of the translational profile, but those are similar to LCLs bearing RPS19 variants. These results link an additional RP gene to DBA. They show that ribosomes can be modified substantially by RPL17 haploinsufficiency but support the paradigm that translation alterations in DBA are primarily related to insufficient ribosome production rather than to changes in ribosome structure or composition.
- 1 August 2024
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 9 (17)
Open AccessAn atypical form of 60S ribosomal subunit in Diamond-Blackfan anemia linked to RPL17 variants
Diamond-Blackfan anemia syndrome (DBA) is a ribosomopathy associated with loss-of-function variants in more than 20 ribosomal protein (RP) genes. Here, we report the genetic, functional, and biochemical dissection of 2 multigenerational pedigrees with variants in RPL17 , a large ribosomal subunit protein–encoding gene. Affected individuals had clinical features and erythroid proliferation defects consistent with DBA. Further, RPL17/uL22 depletion resulted in anemia and micrognathia in zebrafish larvae, and in vivo complementation studies indicated that RPL17 variants were pathogenic. Lymphoblastoid cell lines (LCLs) derived from patients displayed a ribosomal RNA maturation defect reflecting haploinsufficiency of RPL17 . The proteins encoded by RPL17 variants were not incorporated into ribosomes, but 10%–20% of 60S ribosomal subunits contained a short form of 5.8S rRNA (5.8S C ), a species that is marginal in normal cells. These atypical 60S subunits were actively engaged in translation. Ribosome profiling showed changes of the translational profile, but those are similar to LCLs bearing RPS19 variants. These results link an additional RP gene to DBA. They show that ribosomes can be modified substantially by RPL17 haploinsufficiency but support the paradigm that translation alterations in DBA are primarily related to insufficient ribosome production rather than to changes in ribosome structure or composition.